<DOC>
	<DOC>NCT02606734</DOC>
	<brief_summary>The purpose of this study is to evaluate the usability characteristics of DyeVert™ during normal clinical use and to understand the amount of contrast media (CM) diverted from the subject and saved over a total angiographic procedure.</brief_summary>
	<brief_title>DyeVert Pilot Trial</brief_title>
	<detailed_description />
	<criteria>1. The subject is indicated for a coronary angiogram or percutaneous coronary procedure 2. The subject is ≥ 18 years of age 3. The subject (or subject's legal representative) is willing and able to provide appropriate informed consent. 1. Subject is undergoing a STEMI procedure 2. The subject is female and currently pregnant 3. In the investigator's opinion, the subject is not considered to be a suitable candidate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>